- Home
- » Tags
- » Naphazoline
Top View
- Medi-Cal Formulary Is Subject to Change Throughout the Year
- Drug/Substance Trade Name(S)
- Prohibited List 2021
- Council of Europe Committee of Ministers (Partial
- Public Assessment Report Scientific Discussion Orinox HA 1 Mg/Ml
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- CMDP Preferred Drug List 10 01 2019
- Wake Brook Formulary
- January 2021 (PDF)
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Federal Register/Vol. 77, No. 16/Wednesday, January 25, 2012
- Customs Tariff - Schedule
- Examples of Prohibited and Permitted Substances And
- 1. Composition Chlorpheniramine 0.1%W/V Phenylephrine Hydrochloride 0.12% W/V Naphazoline Hydrochloride 0.05% W/V Me
- Rationale for Naphazoline Effects In-Depth Study Borys Kuzminov1*, Vira Turkina2, Yuriy Кuzminov3
- Electronic Supplementary Material (ESI) for Organic & Biomolecular
- NYSDOH Uninsured Care Programs Covered Services and ADAP
- Cluster of Naphazoline and Phenylephrine Intoxications in Children Due to a Compounding Pharmacy Error
- NY Workers' Compensation Drug Formulary – Proposed Update
- Customs Tariff - Schedule Xxi - 1
- Appendix a - Product Name Index
- Preferred Drug List
- A Genome-Wide Positioning Systems Network Algorithm for in Silico Drug Repurposing
- Wo 2007/044693 A2
- Master Drug List
- 2020 Medi-Cal
- Texas HHS Psychiatric Drug Formulary 2021
- National Formulary Part I
- Globalhealth Precision State
- NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%. 2. QU
- Direct-Acting Sympathomimetics STRUCTURE–ACTIVITY
- Euregio Laboratory Services MCP Aimed at Horses – Pharmacologic Drug Library
- Rhinitis Medicamentosa JT Ramey,1 E Bailen,2 RF Lockey1 1 Division of Allergy & Clinical Immunology, University of South Florida & James A
- Brief Summary • Local Anesthetic for Regional Anesthesia [See Package Insert for Full Prescribing Information]
- Jphysiol00514-0646.Pdf
- ICD-10-CM TABLE of DRUGS and CHEMICALS
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- THE USE and MISUSE of DRUGS in SYMPTOMATIC TREATMENT of the ALLERGIC NOSE by KATE MAUNSELL, M.D
- Naphazoline Hydrochloride 0.027% and Pheniramine Maleate 0.315% Ophthalmic Solution, USP (OTC)
- Lmis of the Drugs from GE-HTS Project
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Naphazoline Hydrochloride BP 0.1%W/V Boric Acid BP 1.0%W/V Menthol IP 0.0025%W/V Camphor IP 0.0025%W/V Hydroxypr
- 5 Adrenergic Agonists
- W O 2U11/131472 a L
- Watch for Nonpsychotropics Causing Psychiatric Side Effects
- Alphabetical Listing by Name Naval Hospital Jacksonville Formulary
- Simultaneous Estimation of Naphazoline Hcl and Phenylephrine Hcl by HPLC Method in Eye Drops
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Potentially Inappropriate OTC Medications for the Elderly: a List for Pharmacists
- EFFECTIVE 01/01/2021 Medication Name Change Description Abiraterone Acetate 500 Mg Tablet - Added: Specialty Drug - QL Added: 2 / DAY
- Medicare Part D 2016 Formulary Changes Service to Senior and OC Preferred
- Resolution Ap (2000) 1
- NMCSD and NHCP OUTPATIENT FORMULARY Alphabetical Listing by Name
- Otrivine-Antistin-Pupil, Corneal and Conjunctival Responses to Topical Administration
- Treatments for Seasonal Allergic Rhinitis Comparative Effectiveness Review Number 120
- Naphazoline Hydrochloride Ophthalmic Solution, USP) 0.1% Sterile